Profil
Renee F.
Cohen was a Director at Pfizer, Inc. She was Vice President of Operations & Strategy for NeoStem, Inc. until July 24, 2008 and Co-Founder and Chief Operating Officer of DrugVoice from 2000 to 2002.
Ms. Cohen worked at Accenture from1993 to 2000.
She received a Bachelor of Arts degree from Brandeis University in 1988 and an MBA from New York University's Stern School of Business in 1992.
Anciens postes connus de Renee F. Cohen
| Sociétés | Poste | Fin |
|---|---|---|
Caladrius Biosciences, Inc.
 Caladrius Biosciences, Inc. BiotechnologyHealth Technology Caladrius Biosciences, Inc. is a biopharmaceutical company, which engages in development of cell therapies for select cardiovascular and autoimmune diseases. Its product pipeline includes XOWNA, CLBS12, CLBS201 and CLBS14. The company was founded on September 18, 1980 and is headquartered in Basking Ridge, NJ. | Directeur des opérations | 24/07/2008 |
Formation de Renee F. Cohen
| Brandeis University | Undergraduate Degree |
| New York University | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Caladrius Biosciences, Inc.
Caladrius Biosciences, Inc. BiotechnologyHealth Technology Caladrius Biosciences, Inc. is a biopharmaceutical company, which engages in development of cell therapies for select cardiovascular and autoimmune diseases. Its product pipeline includes XOWNA, CLBS12, CLBS201 and CLBS14. The company was founded on September 18, 1980 and is headquartered in Basking Ridge, NJ. | Health Technology |